TG Therapeutics | TGTX - Passifs Courants

Prix De L'Action
33.72
Variation Quotidienne
-0.06 -0.18%
Mensuellement
0.57%
Annuel
-22.38%
Q2 Prévisions
35.84




Passifs Courants Changement Date
AbbVie USD 43.29B 3.9B 2025-12
Alaunos Therapeutics USD 813K 108K 2025-12
Amgen USD 24.96B 534M 2026-03
Ardelyx USD 109.57M 20.96M 2026-03
Arrowhead Research USD 347.42M 151.94M 2025-12
Bayer EUR 32.58B 3.63B 2025-12
Biogen USD 3B 350.5M 2026-03
Corcept Therapeutics USD 149.18M 16.9M 2026-03
Curis USD 14.08M 5.3M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
Infinity Pharmaceuticals USD 12.06M 775K 2023-06
J&J USD 57.72B 3.59B 2026-03
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Novavax USD 459.95M 30.08M 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Roche Holding CHF 28B 421M 2025-12
TG Therapeutics USD 153.76M 3.05M 2025-12
Verastem USD 72.27M 12.56M 2025-12
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12